ClinConnect ClinConnect Logo
Search / Trial NCT07007897

Observational Study - TA- 2025-1

Launched by HAAG-STREIT AG · Jun 3, 2025

Trial Information

Current as of July 23, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • diagnosed with cataracts (any grade),
  • Seeking cataract treatment,
  • willing to provide informed consent.
  • Exclusion Criteria:
  • Active ocular infections or trauma.
  • Poor fixation ability (e.g., severe nystagmus).
  • Prior intraocular surgery.
  • Seeking toric IOL implantation requiring ink marking.

About Haag Streit Ag

Haag-Streit AG is a globally recognized leader in the development and manufacturing of innovative diagnostic and surgical equipment for the ophthalmic and optometric fields. With a rich history of over 150 years, the company is committed to enhancing patient care through cutting-edge technology and high-quality products. Haag-Streit AG's extensive portfolio includes advanced imaging systems, precision instruments, and robust software solutions, all designed to support healthcare professionals in delivering accurate diagnoses and effective treatments. The organization is dedicated to advancing clinical research and improving visual health outcomes worldwide, making significant contributions to the field of eye care.

Locations

Mesa, Arizona, United States

Eugene, Oregon, United States

Patients applied

0 patients applied

Trial Officials

Jan Rübel, PhD

Study Chair

Haag-Streit

Julian V Kool van Langenberghe, ing

Study Director

Haag-Streit

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported